— Know what they know.
Not Investment Advice

IOBT NASDAQ

IO Biotech, Inc.
1W: -33.2% 1M: -96.8% 3M: -98.8% YTD: -99.1% 1Y: -99.3% 3Y: -99.7%
$0.01
Last traded 2026-04-20 — delisted
NASDAQ · Healthcare · Biotechnology · $885690 mcap · 60M float · 33.10% daily turnover · Short 52% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-88M
Net Income
+2.2% YoY
$-81M
Free Cash Flow
+5.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-240.5%
ROA-136.0%
ROIC257.0%

Valuation

P/E-0.0
P/B0.9
EV/EBITDA0.1

Leverage

Debt/Equity1.60
Current Ratio2.01
Interest Cov.-77.4x

Quality Scores

Piotroski F1/9
Altman Z-20.94
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms